New HIV Vaccine Trial Shows Promise with mRNA Technology
A recent clinical trial is offering new hope in the fight against HIV. Researchers tested a new type of vaccine using mRNA technology—the same method used in COVID-19 vaccines—to see if it could trigger strong immune responses against the virus. The trial, called HVTN 302, tested three different versions of an HIV vaccine in 108
